For nearly 30 years, Mr. Imbriglia defended products liability and toxic tort suits in eastern Pennsylvania. A former prosecutor with the Philadelphia District Attorney’s Office, Mr. Imbriglia regularly practices in the Philadelphia Court of Common Pleas and the Eastern District of Pennsylvania. He represents pharmaceutical, medical device, and product manufacturers in individual cases and mass tort litigation, including personal injury lawsuits, medical monitoring cases, and proposed class actions. In the toxic tort field, Mr. Imbriglia has worked on cases involving exposures to lead, beryllium, PCB’s, benzene, and asbestos. Most recently, Mr. Imbriglia has represented a publishing company accused of conspiring with a pharmaceutical company to conceal the side effects of a prescription drug; summary judgment for our client was entered in the first four cases decided. In another recent litigation, Mr. Imbriglia guided an engineering firm to complete victory in a mass tort in Philadelphia. More than 50 plaintiffs sued the engineering firm, alleging that, because of its negligence, they had contracted chronic beryllium disease or needed to be medically monitored for that condition. The engineering firm had conducted testing revealing high levels of beryllium emissions at a plant in the 1970s and 1980s. Arguing that the engineering firm had a duty to prevent this exposure in various ways, plaintiffs brought personal injury lawsuits and a medical monitoring class action against the firm. After years of discovery and litigation, Mr. Imbriglia won dismissals of the personal injury claims and the class action.
See Reeser v. Spotts, Stevens & McCoy, Inc., 2011 PA Super 17 and Sheridan v. NGK Metals Corp., 609 F.3d 239 (3d Cir. 2010).
In recent years, Mr. Imbriglia has also represented the manufacturer of an insulation product in a nationwide class action where building owners allege that the product “off-gassed,” thereby exposing them to hazardous chemicals; the manufacturer of a component of an insulin-delivery system that was alleged to over- and under-deliver insulin with life-threatening consequences; and the manufacturer of ceiling tiles that allegedly released PCBs and caused cancer in building occupants.
In 2012 and 2013, Mr. Imbriglia has represented a publishing company and its former subsidiary, a medical communications company, in more than 200 cases where plaintiffs allege that they were harmed by a drug whose side effects were concealed or deliberately distorted by the clients as part of a conspiracy with the drug’s manufacturer. In the first four cases to be decided, motions for summary judgment were granted in our clients’ favor. Those decisions were appealed, though the appeals were ultimately dismissed by the plaintiffs. In the meantime, more than forty cases have been dismissed as the plaintiffs search for a way to overcome the court’s rulings.
In addition, Mr. Imbriglia has represented various clients in the following focus areas:
Pharmaceutical and Medical Device Cases
Toxic Tort Cases
Class Actions
Additional Representative Cases
Law Clerk, Superior Court of New Hampshire, 1980-1981
Commonwealth of Pennsylvania|Commonwealth of Massachusetts|United States District Court for the Eastern District of Pennsylvania|United States District Court for the Middle District of Pennsylvania|United States Court of Appeals for the Third Circuit|United States Court of Appeals for the Fourth Circuit
|||||
Listed in Best Lawyers®, Product Liability Litigation – Defendants
Selected to the Pennsylvania Super Lawyers list, Class Action/Mass Torts
AV® Peer Review Rated by Martindale-Hubbell
Recipient of the Chapter Award from the Boston College Law School Alumni Association, 2013
